Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease

Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8 + T cell activation in Kawasaki disease

(2016) Qing Ye et al.   CLINICAL IMMUNOLOGY

Profiles of responses of immunological factors to different subtypes of Kawasaki disease

(2015) Yan Ding et al.   BMC MUSCULOSKELETAL DISORDERS

Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease

(2015) Hiroyuki Wakiguchi et al.   PEDIATRIC RESEARCH

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

(2012) Tohru Kobayashi et al.   LANCET

Kawasaki disease: update on pathogenesis

(2010) Rae SM Yeung   CURRENT OPINION IN RHEUMATOLOGY

Marker of T-cell activation is elevated in refractory Kawasaki disease

(2010) Hiroyuki Suzuki et al.   PEDIATRICS INTERNATIONAL